S1 Ep131: Mitigating AEs and Protecting QOL Following Talquetamab in Multiple Myeloma
CancerNetwork® collaborated with CURE® to speak with Samantha Shenoy, NP, MSN, a nurse practitioner at the Cancer Immunotherapy Clinic of University of California San Francisco (UCSF) Health, about the role she plays when treating patients with multiple myeloma who are receiving talquetamab-tgvs (Talvey). Of note, emphasis was placed on managing treatment-emergent adverse effects (TRAEs) and to...
21m Oct 14, 2024
21m
S1 Ep130: Forming Connections and Making a Difference in the Brain Cancer Field
The only way forward in the brain cancer field is to be open to mentoring others, according to Yoshie Umemura, MD.
20m Oct 07, 2024
20m
S1 Ep129: Exploring the Potential Role of JAK Inhibitors in Multiple Myeloma
James R. Berenson, MD, describes ongoing efforts to evaluate treatment with JAK inhibitors like ruxolitinib among patients with multiple myeloma.
16m Sep 30, 2024
16m
S1 Ep128: Advancing Glioblastoma Research Through a Phase 3 Niraparib Trial
Investigators of the Gliofocus trial look to set a clinically relevant “benchmark” in the glioblastoma field, according to Nader Sanai, MD.
20m Sep 23, 2024
20m
S1 Ep127: Exploring the Value of Preoperative CAPTEM in Atypical Lung NETs
Georgios Evangelou, MD, MSc, speaks to the potential utility of neoadjuvant capecitabine/temozolomide in well-differentiated atypical carcinoids.
8m Sep 16, 2024
8m
S1 Ep126: Improving Quality of Life in Cancer With Physical Medicine & Rehabilitation
Jessica Cheng, MD, highlights how physical medicine and rehabilitation may help optimize function and performance status in patients with cancer.
19m Sep 09, 2024
19m
S1 Ep125: Managing Secondary Cancer Risks After CAR T-Cell Therapy in Multiple Myeloma Subgroups
Experts in multiple myeloma weigh the benefits and risks of administering CAR T-cell therapy to patients based on prior reports of secondary malignancies.
18m Sep 02, 2024
18m
S1 Ep124: Afami-cel Approval May Open Gateway for Synovial Sarcoma Advancements
Brian A. Van Tine, MD, PhD, discusses potential evolutions in the treatment landscape following the FDA approval of afami-cel in metastatic synovial sarcoma.
12m Aug 26, 2024
12m
S1 Ep123: Optimizing Benefits Following Dostarlimab Approval in Endometrial Cancer
CancerNetwork® spoke with Ritu Salani, MD, about the expanded FDA approval of dostarlimab-gxly (Jemperli) in combination with carboplatin/paclitaxel (https://www.cancernetwork.com/view/fda-expands-approval-for-dostarlimab-chemo-in-advanced-endometrial-cancer) for patients with primary advanced or recurrent endometrial cancer.1 Salani, a board-certified gynecologic oncologist and director of Gy...
11m Aug 19, 2024
11m
S1 Ep122: Taking a “Cross-Cutting Approach” With Cancer Vaccinations
Cancer vaccines may pair well with other forms of immunotherapy in the treatment of patients with cancer, according to Catherine J. Wu, MD.
14m Aug 12, 2024
14m
S1 Ep121: Advancing Pancreatic Cancer Care Through Intraoperative Radiation Therapy
Experts from Vanderbilt Medical Center review mechanisms, supporting data, and patient cases associated with the use of IORT in pancreatic cancer.
28m Aug 05, 2024
28m
S1 Ep120: Improving CAR T-Cell Therapy Monitoring Strategies and Access in Lymphoma
Nausheen Ahmed, MD, discusses findings from a study supporting reduced monitoring windows for patients with lymphoma who receive CAR T-cell therapy.
16m Jul 29, 2024
16m
S1 Ep119: Exploring New Possibilities in Kidney Cancer Detection and Therapy
Experts discuss findings related to liquid biopsy profiling, later-line immunotherapy, and CDK4/6 inhibitor efficacy presented at the 2024 KCRS meeting.
10m Jul 22, 2024
10m
S1 Ep118: Overcoming Physical and Social Barriers in the Lymphoma Field
Leaders from the lymphoma space highlight the importance of mentorship in establishing their careers and impart advice to women looking to advance theirs.
19m Jul 15, 2024
19m
S1 Ep117: Epcoritamab Approval Expands Bispecific Use in Follicular Lymphoma
Bispecific antibodies including epcoritamab have “a lot of potential for upward mobility” in lymphoma, according to Tycel Phillips, MD.
13m Jul 08, 2024
13m
S1 Ep116: Leveraging Artificial Intelligence Evolutions in Prostate Cancer Care
AI tools may show utility in areas such as prostate diagnostic imaging, pathology, and treatment outcome predictions.
32m Jul 01, 2024
32m
S1 Ep115: Ensuring Quality Outcomes in Hematologic Cancer Subgroups at EHA 2024
Experts discuss updated findings presented at the 2024 EHA Congress in diseases such as mantle cell lymphoma and acute myeloid leukemia.
8m Jun 24, 2024
8m
S1 Ep114: Applying Updated Breast Cancer Findings From ASCO to Clinical Practice
Following the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, (https://www.cancernetwork.com/conference/asco) Neil M. Iyengar, MD, and Paolo Tarantino, MD, co-hosted a live X Space with CancerNetwork® and discussed the latest trial updates that may impact clinical practice in the breast cancer field. Iyengar is an associate attending physician at Memorial Sloan Kettering Canc...
31m Jun 17, 2024
31m
S1 Ep113: Optimizing Metastatic CRC Outcomes Following Fruquintinib Approval
In a conversation with CancerNetwork®, Jagoda Misniakiewicz, PharmD, a clinical pharmacy specialist in the Clinical Pharmacy and Outcomes Sciences Department at Hollings Cancer Center of the Medical University of South Carolina, spoke about the use of fruquintinib (Fruzaqla) as a treatment option for those with metastatic colorectal cancer (CRC). The FDA previously approved fruquintinib as a t...
14m Jun 10, 2024
14m
S1 Ep112: Optimizing NSCLC Outcomes Via Technological Advances in Radiation Oncology
In a conversation with CancerNetwork®, Terence T. Sio, MD, MS, discussed how technological advancements in radiation oncology have impacted the modern treatment landscape for patients with non–small cell lung cancer (NSCLC). Sio, a professor of radiation oncology at Mayo Clinic in Phoenix, Arizona, first outlined the use of immunotherapy and other systemic treatment options for this patient po...
27m Jun 03, 2024
27m
S1 Ep111: Ensuring Quality Rectal Cancer Surgery at NAPRC-Accredited Institutions
Through elaborate multidisciplinary collaboration, institutions with National Accreditation Program for Rectal Cancer (NAPRC) standards can deliver a “high level of care” in the surgical treatment of patients with rectal cancer, according to Steven Wexner, MD, PhD, and Arielle Kanters, MD. In a conversation with CancerNetwork®, Wexner and Kanters detailed the history and advancement of the NAP...
22m May 27, 2024
22m
S1 Ep110: Finding a Place for Exercise Oncology in the Treatment of Breast Cancer
In a conversation with CancerNetwork® at Memorial Sloan Kettering Cancer Center (MSKCC), Neil M. Iyengar, MD, spoke about developments and challenges in his career as a medical oncologist and clinical investigator as well as ongoing research efforts in improving outcomes among patients with breast cancer. Iyengar, a breast oncologist in in the Department of Medicine at MSKCC and Weill Cornell ...
25m May 20, 2024
25m
S1 Ep109: Leveraging Surgical Oncology Advances in Colorectal Cancer Care
In a discussion with CancerNetwork® at John Theurer Cancer Center, Gregory Charak, MD, highlighted advancements in surgical treatment strategies for patients with colorectal cancer (CRC) as well as other ongoing challenges in the field. Specifically, Charak, a board-certified colorectal surgeon at Palisades Medical Center and Hackensack University Medical Center of Hackensack Meridian Health, ...
6m May 13, 2024
6m
S1 Ep108: Administering CAR T-Cell Therapy and Bispecific Agents in Nursing Practice
During the 2024 Oncology Nursing Society Congress (https://www.cancernetwork.com/conference/ons) , CancerNetwork® spoke with multiple registered nurses about research they presented on safely administering treatment options such as CAR T-cell therapy and bispecific T-cell engager (BiTE) therapy in patients with multiple myeloma and other malignancies. Ishmael Applewhite, BSN, RN-BC, OCN, (http...
9m May 06, 2024
9m
S1 Ep107: Applying Novel Radiotherapy Technology for Brain Tumors and Other Cancers
In a conversation with CancerNetwork® at John Theurer Cancer Center, Timothy Chen, MD, highlighted various novel treatment strategies that have impacted his care of patients with brain tumors and other types of cancer. Chen, a board-certified radiation oncologist and medical director of the Central Nervous System Program at Jersey Shore University Medical Center and the director of Proton Ther...
18m Apr 29, 2024
18m
S1 Ep106: Moving The Needle in Lung Cancer Management With Robotic-Assisted Surgery
The robotic-assisted biopsy platform Ion is a “game-changer” for patients with lung cancer, as it provides a quicker, less invasive surgical method for conducting a lung biopsy, according to Richard Lazzaro, MD. In a conversation with CancerNetwork, Lazzaro, the chief of Thoracic Surgery at the Southern Region of RWJBarnabas Health, spoke about his experience with adopting the Ion robotic bron...
20m Apr 22, 2024
20m
S1 Ep105: Surgeons Talk Key Treatment and Institutional Advances Across Oncology Care
During the 2024 Society of Surgical Oncology Annual Meeting (SSO) (https://www.cancernetwork.com/conference/sso) , CancerNetwork® spoke with a variety of surgical oncology experts regarding the topline data they presented. Each conversation also expanded upon how these results can be implemented into the clinical space and the next research steps. First, Adrienne Bruce Shannon, MD (https://www...
20m Apr 15, 2024
20m
S1 Ep104: Finding Ways to Break the Mold in GU Oncology
As part of Breaking Barriers: Women in Oncology, Maha H. Hussain, MD, and Sarah E. Fenton, MD, PhD, spoke with CancerNetwork® about developments in their careers and the evolution of research in the genitourinary oncology (GU) field. Additionally, they discussed their personal experiences in the field, which ranged from applying key pieces of advice from former mentors, handling challenges, and...
36m Apr 08, 2024
36m
S1 Ep103: Achieving Health Equity in Lung Cancer Surgery
In a conversation with CancerNetwork®, Rian M. Hasson Charles, MD, MPH, FACS, spoke about her career in thoracic surgery (https://www.cancernetwork.com/view/forging-a-path-in-thoracic-surgery-to-create-a-stellar-career) and her visions for increasing equitable care in the field as part of a new, first-of-its-kind role at Brigham and Women’s Hospital. She will serve as the inaugural vice chair f...
33m Apr 01, 2024
33m
S1 Ep102: Updated ASCO Guidelines for Optimal Small Cell Lung Cancer Management
In a conversation with CancerNetwork®, Gregory Peter Kalemkerian, MD, spoke about the publication of updated guidelines for managing small cell lung cancer (SCLC) with systemic therapy, which was developed by the American Society of Clinical Oncology (ASCO) in collaboration with Ontario Health (Cancer Care Ontario).1 Kalemkerian, a clinical professor at The University of Michigan and senior au...
26m Mar 25, 2024
26m
S1 Ep101: Creating a First-of-Its-Kind Integrative Oncology Program at City of Hope
CancerNetwork® collaborated with OncLive® to speak with Edward S. Kim, MD, MBA, and Richard T. Lee, MD, about ongoing initiatives to expand integrative oncology for patients with cancer at City of Hope. Kim is the physician-in-chief and senior vice president at City of Hope Orange County as well as the Construction Industries Alliance City of Hope Orange County physician-in-chief chair. Lee is...
29m Mar 18, 2024
29m
S1 Ep100: Addressing Rising Cancer Incidence and Burden in Younger Populations
Monique Gary, DO, MSc, FACS spoke with CancerNetwork® about estimated increases in cancer burden across the world and the potential rises in cancer inequities among underserved populations, and discussed mitigating these disparities from an oncology and primary care perspective. Gary, a board-certified breast surgical oncologist and medical director of the Grand View Health/Penn Cancer Network...
15m Mar 11, 2024
15m
S1 Ep99: How to Expand Health Equity in Oncology
In a conversation with CancerNetwork®, Robert A. Winn, MD, spoke about current obstacles in achieving equitable care for patients with cancer and discussed how initiatives from community health centers and federal bodies alike may help increase access to anti-cancer therapy. Winn, director and Lipman Chair in Oncology at Virginia Commonwealth University (VCU) Massey Comprehensive Cancer Center...
11m Mar 04, 2024
11m
S1 Ep98: Diane M. Simeone, MD “Thrilled” To Be UCSD Moores Cancer Center Director
Starting April 1, 2024, Diane M. Simeone, MD will start her new position as director of the University of California San Diego (UCSD) Health Moores Cancer Center.1 In a conversation with CancerNetwork®, Simeone highlighted her excitement to be working with an institution that she said aligns with her goals and values. During her time as director, she said that she wants to focus more on early ...
17m Feb 26, 2024
17m
S1 Ep97: Expert Perspectives on 2024 ASCO GI Cancers Symposium Trial Updates
After the 2024 Gastrointestinal Cancers Symposium, (https://www.cancernetwork.com/conference/asco-gastrointestinal-cancer-symposium) Jun Gong, MD, and Daneng Li, MD, sat down to discuss the most relevant trial data to have come from the conference. They convened for a live X Space hosted by CancerNetwork®. During the discussion, they covered different trials across the gastrointestinal space, ...
31m Feb 19, 2024
31m
S1 Ep96: Combatting Stigmatization to Increase Lung Cancer Screening Access
In a conversation with CancerNetwork®, Lisa Carter-Bawa PhD, MPH, APRN, ANP-C, FAAN, spoke about factors that may contribute to feelings of stigmatization surrounding a lung cancer diagnosis, which may impact an individual’s decision to undergo screening for potential disease. Specifically, Carter-Bawa, director of the Cancer Prevention Precision Control Institute at the Hackensack Meridian He...
16m Feb 12, 2024
16m
S1 Ep95: Unraveling Resistance and Heterogeneity in Mantle Cell Lymphoma Management
Although strides have been made with Bruton tyrosine kinase (BTK) inhibitors and CAR-T cell therapy, relapse and resistance remain significant hurdles in treating patients with mantle cell lymphoma (MCL). The Lymphoma Research Foundation's 2023 MCL Scientific Consortium and Workshop addressed these complexities, aiming to dissect the intricate biology of MCL and propel progress towards a cure. ...
11m Feb 05, 2024
11m
S1 Ep94: SIO/ASCO Guidelines for Integrative Therapies to Manage Anxiety/Depression
Integrative therapies have been proven to help reduce the adverse effects (AEs) of anxiety and depression in patients with cancer, according to Linda E. Carlson, PhD, RPsych. Carlson, Enbridge Research Chair in Psychosocial Oncology and a professor in the Department of Oncology, Cumming School of Medicine at the University of Calgary, explained how different therapies such as mindfulness-based...
12m Jan 29, 2024
12m
S1 Ep93: Jyoti S. Mayadev, MD, on Pembrolizumab/CRT FDA Approval in Cervical Cancer
In a conversation with CancerNetwork® prior to the FDA approval of pembrolizumab (Keytruda) plus chemoradiotherapy (https://www.cancernetwork.com/view/fda-approves-pembrolizumab-chemoradiation-in-high-risk-cervical-cancer) in FIGO stage III to IVA cervical cancer, Jyoti S. Mayadev, MD, spoke about how the regimen’s approval would be a “major step” for the aforementioned population and how she p...
10m Jan 22, 2024
10m
S1 Ep92: Managing CDK4/6 Inhibitor, ADC Toxicity in Metastatic Breast Cancer
In a conversation with CancerNetwork®, Sarah Donahue, MPH, NP, discussed strategies for managing adverse effects (AEs) associated with different drug classes for patients with metastatic breast cancer, ranging from antibody drug conjugates (ADCs) to CDK4/6 inhibitors. With respect to ADCs, Donahue, a nurse practitioner at University of California, San Francisco, and member of the Oncology Nurs...
22m Jan 15, 2024
22m
S1 Ep91: HER2CLIMB-02 Trial Shows ‘Interesting Data’ in HER2+ Breast Cancer
In a recent conversation with CancerNetwork®, Sara A. Hurvitz, MD, FACP, senior vice president and director of the Clinical Research Division at Fred Hutch Cancer Center and head of the Division of Hematology and Oncology at the University of Washington Department of Medicine, discussed new treatment options for patients with metastatic HER2-positive breast cancer. In the discussion, Hurvitz h...
13m Jan 09, 2024
13m
S1 Ep90: Frontline Chemo-Free Regimen Supported in HR+/HER2+ Breast Cancer Therapy
In a conversation with CancerNetwork®, Amy Tiersten, MD, spoke about how findings from the phase 1/2 ASPIRE trial (NCT03304080) may support anastrozole (Arimidex) plus palbociclib (Ibrance), trastuzumab (Herceptin), and pertuzumab (Perjeta) as a first-line treatment for patients with hormone receptor (HR)–positive, HER2-positive metastatic breast cancer. Data presented at the 2023 San Antonio ...
6m Jan 01, 2024
6m
S1 Ep89: Expert Discusses Screening Advocacy, AI, and Developments in Breast Cancer
In a conversation with CancerNetwork®, Rakshanda Rahman, MD, FRCS, FACS, discussed a wide range of surgical therapy strategies and other developments in the breast cancer space, ranging from factors that should be considered for surgical decision-making to the evolution of artificial intelligence (AI) in the field. Rahman, a professor of Breast Surgical Oncology at Texas Tech University Health...
24m Dec 18, 2023
24m
S1 Ep88: Joleen Hubbard, MD, Highlights The “Exciting Space” Of Metastatic CRC
In a recent discussion with CancerNetwork®, Joleen Hubbard, MD, research collaborator with Mayo Clinic and deputy director for clinical research at Allina Health Cancer Institute in Minneapolis, Minnesota, discussed new opportunities for patients with colorectal cancer (CRC). In the discussion, Hubbard highlighted the potential of trastuzumab deruxtecan-nxki (Enhertu; T-DXd) in patients with H...
9m Dec 11, 2023
9m
S1 Ep87: Adapting to a Robotic Workstation for Image-Guided Liver Cancer Surgery
CancerNetwork® spoke with Govindarajan Narayanan, MD about his practice becoming the first in the United States to successfully surgically treat a patient with a liver tumor using the Epione robot, as well as the process of transitioning from CT-based image guidance to the robotic workstation in his care.1 Narayanan, a professor of Radiology and an interventional radiologist at Miami Cardiac a...
13m Dec 04, 2023
13m
S1 Ep86: Tanios S. Bekaii-Saab, MD, Speaks to Expanding Horizons in CRC Treatment
During an overview of the current standard of care for patients with colorectal cancer (CRC) (https://www.cancernetwork.com/view/future-crc-treatment-to-focus-on-mutation-status-expert-says) , Tanios S. Bekaii-Saab, MD noted that as molecular testing becomes more important, researchers are looking into how to best personalize therapy for optimal outcomes. He spoke with CancerNetwork® as part of...
8m Nov 27, 2023
8m
S1 Ep85: Multidisciplinary Care and New Treatment Options in CRC
Kristen K. Ciombor, MD, MSCI, an assistant professor in the Division of Hematology/Oncology in the Department of Medicine at the Vanderbilt University Medical Center, recently spoke at an Around the Practice discussion regarding updates in the world of metastatic colorectal cancer (CRC). In this episode of the ONCOLOGY® On the Go Podcast, she discusses treatment updates, molecular testing opti...
5m Nov 20, 2023
5m
S1 Ep84: Multidisciplinary Care, Approval Updates, and Future Research in NSCLC
As part of an Around the Practice (https://www.cancernetwork.com/around-the-practice/advancements-in-treatment-management-strategies-for-egfr-mutated-nsclc-insights-from-experts-at) program, CancerNetwork® spoke with Misako Nagasaka, MD, PhD, about her current treatment strategies for patients with lung cancer as well as relevant updates and potential advancements in the non–small cell lung can...
11m Nov 13, 2023
11m
S1 Ep83: Psychosocial Approach to Sexual Dysfunction During and After Cancer Treatment
Sexual dysfunction is a common problem for patients with and survivors of cancer that often remains undertreated. It can manifest in a variety of ways, including reduced libido, sexual pain, and vaginal dryness. Jennifer A. Vencill, PhD, LP, takes a biopsychosocial approach to sexual health, helping to address the psychological aspects of sexual dysfunction. In this episode of the ONCOLOGY On ...
11m Nov 08, 2023
11m
S1 Ep82: Experts Discuss Differences in Radiotherapy Outcomes in BRCA+ Breast Cancer
During Breast Cancer Awareness Month 2023,  (https://www.cancernetwork.com/awareness-month/september-2023-breast-cancer-awareness-month) Rebecca M. Shulman, MD, an assistant professor in the Department of Radiation Oncology at Fox Chase Cancer Center, and Zachary Kiss, DO, a third-year resident physician in radiation oncology at Fox Chase, spoke about findings from their study, which assessed h...
16m Oct 30, 2023
16m